Control_NN
of_IN
cell_NN
cycle_NN
entry_NN
and_CC
apoptosis_NN
in_IN
B_NN
lymphocytes_NNS
infected_VBN
by_IN
Epstein-Barr_JJ
virus_NN
._.

Infection_NN
of_IN
human_JJ
B_NN
cells_NNS
with_IN
Epstein-Barr_JJ
virus_NN
-LRB-_-LRB-
EBV_NN
-RRB-_-RRB-
results_VBZ
in_IN
activation_NN
of_IN
the_DT
cell_NN
cycle_NN
and_CC
cell_NN
growth_NN
._.

To_TO
interpret_VB
the_DT
mechanisms_NNS
by_IN
which_WDT
EBV_NN
activates_VBZ
the_DT
cell_NN
,_,
we_PRP
have_VBP
assayed_VBN
many_JJ
proteins_NNS
involved_VBN
in_IN
control_NN
of_IN
the_DT
G0_NN
and_CC
G1_NN
phases_NNS
of_IN
the_DT
cell_NN
cycle_NN
and_CC
regulation_NN
of_IN
apoptosis_NN
._.

In_IN
EBV_NN
infection_NN
most_JJS
of_IN
the_DT
changes_NNS
,_,
including_VBG
the_DT
early_JJ
induction_NN
of_IN
cyclin_NN
D2_NN
,_,
are_VBP
dependent_JJ
on_IN
expression_NN
of_IN
EBV_NN
genes_NNS
,_,
but_CC
an_DT
alteration_NN
in_IN
the_DT
E2F-4_NN
profile_NN
was_VBD
partly_RB
independent_JJ
of_IN
viral_JJ
gene_NN
expression_NN
,_,
presumably_RB
occurring_VBG
in_IN
response_NN
to_TO
signal_NN
transduction_NN
activated_VBN
when_WRB
the_DT
virus_NN
binds_VBZ
to_TO
its_PRP$
receptor_NN
,_,
CD21_NN
._.

By_IN
comparing_VBG
the_DT
expression_NN
of_IN
genes_NNS
controlling_VBG
apoptosis_NN
,_,
including_VBG
those_DT
encoding_VBG
several_JJ
members_NNS
of_IN
the_DT
BCL-2_NN
family_NN
of_IN
proteins_NNS
,_,
the_DT
known_JJ
relative_JJ
resistance_NN
of_IN
EBV-immortalized_JJ
B-cell_NN
lines_NNS
to_TO
apoptosis_NN
induced_VBN
by_IN
low_JJ
serum_NN
was_VBD
found_VBN
to_TO
correlate_VB
with_IN
expression_NN
of_IN
both_CC
BCL-2_NN
and_CC
A20_NN
._.

A20_NN
can_MD
be_VB
regulated_VBN
by_IN
the_DT
NF-kappaB_NN
transcription_NN
factor_NN
,_,
which_WDT
is_VBZ
known_VBN
to_TO
be_VB
activated_VBN
by_IN
the_DT
EBV_NN
LMP-1_NN
protein_NN
._.

Quantitative_JJ
assays_NNS
demonstrated_VBD
a_DT
direct_JJ
temporal_JJ
relationship_NN
between_IN
LMP-1_NN
protein_NN
levels_NNS
and_CC
active_JJ
NF-kappaB_NN
during_IN
the_DT
time_NN
course_NN
of_IN
infection_NN
._.

